Aspitrate G 60 mg/150 mg Capsule
By Aspitrate G
Rx
15 Capsule in a Strip

Composition
Isosorbide Mononitrate(60mg) + Aspirin(150mg)

Manufacturer - Aristo Pharmaceuticals Pvt Ltd
Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

Expires on or after
January, 2026

liver
Aspitrate G 60 mg/150 mg Capsule is considered likely safe for individuals with liver disease based on the currently available data. It appears that no specific dose adjustment is required for these patients. However, it is strongly advised to consult with your doctor before using Aspitrate G 60 mg/150 mg Capsule if you have any liver concerns.

kidney
Aspitrate G 60 mg/150 mg Capsule should be used with caution in patients with kidney disease. Dose adjustment may be needed. Avoid use in severe kidney disease. Consult your doctor for guidance.

alcohol
When using Aspitrate G 60 mg/150 mg Capsule, avoid alcohol to prevent symptoms like flushing, increased heart rate, nausea, thirst, chest pain, and low blood pressure (Disulfiram reaction).

driving
Aspitrate G 60 mg/150 mg Capsule may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
Aspitrate G 60 mg/150 mg Capsule is considered unsafe during pregnancy due to the risk to the developing baby. It may be prescribed in life-threatening situations after consulting the doctor.

breastfeeding
Aspitrate G 60 mg/150 mg Capsule may not be safe for breastfeeding. Limited data indicates the drug could transfer to breastmilk and pose a risk to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | - |
| Action Class | - |
₹27.83
₹30.92
9.99% OFF
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025
